These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17132725)

  • 21. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
    Zhang X; Wei H; Wang H; Tian Z
    Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
    Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
    Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats.
    Bachstetter AD; Morganti JM; Jernberg J; Schlunk A; Mitchell SH; Brewster KW; Hudson CE; Cole MJ; Harrison JK; Bickford PC; Gemma C
    Neurobiol Aging; 2011 Nov; 32(11):2030-44. PubMed ID: 20018408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure.
    Koziolek MJ; Müller GA; Zapf A; Patschan D; Schmid H; Cohen CD; Koschnick S; Vasko R; Bramlage C; Strutz F
    Nephrol Dial Transplant; 2010 Mar; 25(3):684-98. PubMed ID: 19934081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
    Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
    Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
    Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
    Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow.
    Fong AM; Robinson LA; Steeber DA; Tedder TF; Yoshie O; Imai T; Patel DD
    J Exp Med; 1998 Oct; 188(8):1413-9. PubMed ID: 9782118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
    Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB
    J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractalkine (FRK) levels in amniotic fluid and its production during pregnancy.
    Shimoya K; Zhang Q; Tenma K; Ota Y; Hashimoto K; Shizusawa Y; Kimura T; Koyama M; Murata Y
    Mol Hum Reprod; 2003 Feb; 9(2):97-101. PubMed ID: 12569179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors.
    Yamin R; Kaynan NS; Glasner A; Vitenshtein A; Tsukerman P; Bauman Y; Ophir Y; Elias S; Bar-On Y; Gur C; Mandelboim O
    PLoS Pathog; 2013 Aug; 9(8):e1003568. PubMed ID: 23966863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis of renal tubular cells in Shiga-toxin-mediated hemolytic uremic syndrome.
    Kaneko K; Kiyokawa N; Ohtomo Y; Nagaoka R; Yamashiro Y; Taguchi T; Mori T; Fujimoto J; Takeda T
    Nephron; 2001 Feb; 87(2):182-5. PubMed ID: 11244315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CX(3)CR1 and vascular adhesion protein-1-dependent recruitment of CD16(+) monocytes across human liver sinusoidal endothelium.
    Aspinall AI; Curbishley SM; Lalor PF; Weston CJ; Blahova M; Liaskou E; Adams RM; Holt AP; Adams DH
    Hepatology; 2010 Jun; 51(6):2030-9. PubMed ID: 20512991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.
    Jung S; Aliberti J; Graemmel P; Sunshine MJ; Kreutzberg GW; Sher A; Littman DR
    Mol Cell Biol; 2000 Jun; 20(11):4106-14. PubMed ID: 10805752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
    Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
    Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction.
    Bolovan-Fritts CA; Spector SA
    Blood; 2008 Jan; 111(1):175-82. PubMed ID: 17895402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
    Davis CN; Zujovic V; Harrison JK
    Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractalkine--a local inflammatory marker aggravating platelet activation at the vulnerable plaque.
    Flierl U; Schäfer A
    Thromb Haemost; 2012 Sep; 108(3):457-63. PubMed ID: 22739755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes.
    Kobayashi T; Okamoto S; Iwakami Y; Nakazawa A; Hisamatsu T; Chinen H; Kamada N; Imai T; Goto H; Hibi T
    Inflamm Bowel Dis; 2007 Jul; 13(7):837-46. PubMed ID: 17285595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
    Ray PE; Liu XH
    Pediatr Nephrol; 2001 Oct; 16(10):823-39. PubMed ID: 11605791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.